RxDoctor Payments Data

Wallace Johnson, MD

Hypertension Specialist · Baltimore, MDNPI 1043253867

Payments from drug & device makers

$43,077in general payments, 2019–2025

Across 33 payments — averaging $1305.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$23K
  • Novartis$20K
  • Novo Nordisk$111
$536in research payments, 2019–2025

Across 5 payments — averaging $107.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$536

What the payments were for

  • Travel & lodging$81854%
  • Food & beverage$68546%

General payments by program year

20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS19$22,827
Novartis13$20,139
Novo Nordisk1$111

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hypertension specialist providers in Marylandto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$89,387
Medicare patients
262
Services billed
692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$59,464
JardianceEmpagliflozin18$27,711
JanuviaSitagliptin Phosphate13$11,346
Atorvastatin Calcium323$6,543
Eplerenone49$6,116
Ezetimibe82$5,545
Nifedipine ErNifedipine151$5,418
Clonidine50$4,342
Amlodipine Besylate329$4,201
Losartan Potassium237$3,751
Rosuvastatin Calcium73$2,927
Metoprolol Succinate97$2,614
Esomeprazole Magnesium22$1,998
Labetalol Hcl37$1,572
Ventolin HfaAlbuterol Sulfate13$1,506

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →